Novo Nordisk (NVO) stock dipped early Wednesday on mixed third-quarter results as sales of weight-loss drug Wegovy beat expectations, but Ozempic came in light.
...
Vertex Pharmaceuticals (VRTX) beat Wall Street's third-quarter expectations late Monday, but an analyst says Vertex stock needs more than that "to drive another leg...
TG Therapeutics (TGTX) stock crashed Monday — reversing a breakout — after missing third-quarter profit expectations, though sales of its multiple sclerosis treatment beat...
Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating...
Madrigal stock catapulted higher again Friday after Novo Nordisk (NVO) published promising — but not "game-changing" — results for its weight-loss drug in patients...